spacer
home > pmps > summer 2019 > a seamless supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Seamless Supply

Clinical trials can vary in their scope and design and can be either single-site or multi-site, happening in a single country or in several geographical areas. In some clinical areas, studies are becoming larger and more complex, while the sponsors desire faster recruitment and data generation. Multi-site, multi-country studies are challenging as they require the coordination of many different parameters such as manufacturing, packaging, temperature management, storage, and distribution.

Clinical trials usually comprise three different stages: the study preparation, the active study (between ‘first patient, first visit’ and ‘last patient, last visit’) and the finalisation of the study (after ‘last patient, last visit’). Each of these stages will face different challenges of the logistics and supply chain that must be controlled.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Celine Chanforan graduated with a Masters in Food Science from the University of Montpellier, France, in 2006, and achieved her PhD in Food Chemistry from the University of Avignon, France, in 2010. Celine started her career as Project Manager in the food ingredient sector for nine years. Celine mainly managed R&D projects for food colours and dietary supplements. After moving to the UK in 2016, Celine has been in charge of projects related to the delivery of new immunoassay tests for various applications and in accordance with in vitro diagnostic quality management system ISO 13485. In 2017, Celine joined Onorach as Clinical Project Manager and is now in charge of the international clinical project portfolio.
spacer
Celine Chanforan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI MEA expert:growing domestic manufacturing is creating new opportunities for international Pharma in the Middle East

Abu Dhabi, 5th August 2019: CPhI Middle East expert Emad Shabbir, Director at EMAD Trade House, states favorable conditions and legislative regulations in Saudi Arabia are resulting in a boom of manufacturers and CMOs partnerships with international pharma companies. With the strategic cooperation between regional generic companies and multinational pharma companies, driving increased local production.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement